Vaccines - What Are They & What Do They Do?
A vaccine—also called a “shot” or “immunization”— is a substance that teaches your body's immune system to recognize and defend against harmful viruses or bacteria.
Vaccines given before you get infected are called “preventive vaccines” or “prophylactic vaccines,” and you get them while you are healthy. This allows your body to set up defences against those dangers ahead of time. That way, you won't get sick if you're exposed to diseases later. Preventive vaccines are widely used to prevent diseases like polio, chicken pox, measles, mumps, rubella, influenza (flu), hepatitis A and B, and human papillomavirus (HPV).
Where Do I get a Vaccine for HIV?
Unfortunately, there is currently no vaccine available that will prevent HIV infection or treat those who have it.
However, scientists and organisations such as The Aurum Institute are working to develop one. Building on the findings of an earlier study that found for the first time, albeit modestly, that a vaccine could prevent HIV infection in 2016, an NIH-supported clinical trial was launched to test a modified HIV vaccine. This current vaccine trial, called HVTN 702, is testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults.
Learn more about the development of HIV vaccine candidates and the launch of the NIAID-supported HVTN 702 clinical trial in South Africa, the first new HIV vaccine efficacy study in seven years, in the video below:
Why Do We Need An HIV Vaccine?
Today, more people living with HIV than ever before have access to life-saving treatment with HIV medicines (called antiretroviral therapy or ART), which is good for their health. When people living with HIV achieve and maintain viral suppression by taking medication as prescribed, they can stay healthy for many years and greatly reduce their chance of transmitting HIV to their partners. In addition, others who are at high risk for HIV infection may have access to pre-exposure prophylaxis (PrEP), or ART being used to prevent HIV. Yet, unfortunately, in 2015, more than 2.1 million people became newly infected with HIV worldwide. To control and ultimately end HIV globally, we need a powerful array of HIV prevention tools that are widely accessible to all who would benefit from them.
Vaccines historically have been the most effective means to prevent and even eradicate infectious diseases. They safely and cost-effectively prevent illness, disability, and death. Like smallpox and polio vaccines, a preventive HIV vaccine could help save millions of lives.
Developing safe, effective, and affordable vaccines that can prevent HIV infection in uninfected people is the NIH’s highest HIV research priority given its game-changing potential for controlling and ultimately ending the HIV/AIDS pandemic.
The long-term goal is to develop a safe and effective vaccine that protects people worldwide from getting infected with HIV. However, even if a vaccine only protects some people who get vaccinated, or even if it provides less than total protection by reducing the risk of infection, it could still have a major impact on the rates of transmission and help control the pandemic, particularly for populations at high risk of HIV infection. A partially effective vaccine could decrease the number of people who get infected with HIV, further reducing the number of people who can pass the virus on to others. By substantially reducing the number of new infections, we can stop the epidemic.